📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

A CD44-/CD24+ phenotype is a poor prognostic marker in early invasive breast cancer (2011)

First Author: Ahmed M

Attributed to: DPFS Devolved Portfolio (Pilot) funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1007/s10549-011-1865-8

PubMed Identifier: 22119938

Publication URI: http://europepmc.org/abstract/MED/22119938

Type: Journal Article/Review

Parent Publication: Breast Cancer Research and Treatment

Issue: 3

ISSN: 0167-6806